AzTrials
AzTrials

Vaccine HesitancyCOVANEWNCT05582564

The Effect of Newspaper Reporting on COVID-19 Vaccine Hesitancy: a Randomised Controlled Trial

A study testing abstract vs concrete texts in people with Vaccine Hesitancy, run by University of Bari Aldo Moro at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

COVID-19 vaccine hesitancy can be observed at different rates in different countries. 1,068 people were surveyed in France and Italy to inquire about individual potential acceptance, focusing on time preferences, in a risk-return framework: having the vaccination today, in a month, and in 3 months; perceived risks of… Read more about this study

Who is it for?
Ages 18 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Vaccine Hesitancy
What is being tested?
abstract vs concrete texts
Type of treatment
Vaccines
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,068 participants
Where
1 siteItaly
Study dates
2 Jun 2021to 31 Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • unvaccinated individuals

Who cannot join

  • vaccinated individuals

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • University of Bari Aldo Moro

    Bari, 70121

Other trials in Italy

About this study

COVID-19 vaccine hesitancy can be observed at different rates in different countries. 1,068 people were surveyed in France and Italy to inquire about individual potential acceptance, focusing on time preferences, in a risk-return framework: having the vaccination today, in a month, and in 3 months; perceived risks of vaccination and COVID-19; and expected benefit of the vaccine. A randomized controlled trial was conducted to understand how everyday stimuli, such as fact-based news about vaccines, impact on audience acceptance of vaccination. The main experiment involved two groups of participants and two different articles about vaccine-related thrombosis taken from two Italian newspapers. One article used a more abstract description and language, and the other used a more anecdotical description and concrete language; each group read only one of these articles. Two other groups were assigned categorization tasks; one was asked to complete a concrete categorization task and the other an abstract categorization task.

Read the detailed description

The goal of this RCT is to learn how journalistic news can affect vaccine hesitancy. 2 cohorts of unvaccinated individual, one Italian, one French. 5 arms design:

  1. participants reading a fact-based newspaper article written in an abstract language
  2. participants reading a fact-based newspaper article written in a more concrete language
  3. participants performing abstract categorization task
  4. participants performing concrete categorization task
  5. control group answering questionnaire

Research questions:

  1. Does a more abstract vs concrete language increase the willingness to receive the vaccine? ii) Does a more abstract vs concrete mindset increase the willingness to receive the vaccine? iii) Is a gender effect detectable?
Being tested
abstract vs concrete texts
Keywords
vaccine hesitancy
Medical subject headings
Vaccination Hesitancy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • abstract vs concrete textsOther

    Also called abstract vs concrete tasks

    The main experiment involved two groups of participants and two different articles about vaccine-related thrombosis taken from two Italian newspapers. One article used a more abstract descriptive style and language, while the other used a more anecdotical style and concrete language: each group read only one of these articles. Both articles are the same length and describe an episode of vaccine-related thrombosis. The abstract text uses a more formal and impersonal language, reporting more scientific considerations; the concrete text uses a more familiar and emotional style and provides a more anecdotical description of the case. Texts were also weighted according to a concreteness semantic vocabulary. French received translated versions.Two other groups were assigned categorization tasks; one was asked to complete a concrete categorization task and the other an abstract categorization task.

Study groups in NCT05582564
Study groupRoleWhat they receive
concrete textOtherItalian and French unvaccinated cohorts (n= 164; n=163)
Receives: Other: abstract vs concrete texts
abstract textOtherItalian and French unvaccinated cohorts (n=155; n=153)
Receives: Other: abstract vs concrete texts
abstract taskOtherItalian and French unvaccinated cohorts (n=54; n=55)
Receives: Other: abstract vs concrete texts
concrete taskOtherItalian and French unvaccinated cohorts (n=55; n=56)
Receives: Other: abstract vs concrete texts
controlOtherItalian and French unvaccinated cohorts (n=103; n=110)
Receives: Other: abstract vs concrete texts

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. vaccine hesitancy; number of participants accepting the vaccination

    revealed preferences

    Measured: same day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2022
  2. Study start2 Jun 2021
  3. Primary completion20 Jun 2021
  4. Study completion31 Jan 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
1,068 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05582564
Sponsor's protocol ID
00001
Acronym
COVANEW
Status last verified
Oct 2022
First submitted
13 Oct 2022
Last updated
17 Oct 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: No personal data have been collected. Individual responses to the questionnaire will be shared without personal information of respondents on a public repository.

Publications

  • Liberman N, Trope Y. Traversing psychological distance. Trends Cogn Sci. 2014 Jul;18(7):364-9. doi: 10.1016/j.tics.2014.03.001. Epub 2014 Apr 10.

    PubMed 24726527
  • Trope Y, Liberman N. Temporal construal. Psychol Rev. 2003 Jul;110(3):403-21. doi: 10.1037/0033-295x.110.3.403.

    PubMed 12885109
  • Loomba S, de Figueiredo A, Piatek SJ, de Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021 Mar;5(3):337-348. doi: 10.1038/s41562-021-01056-1. Epub 2021 Feb 5.

    PubMed 33547453
  • MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015 Aug 14;33(34):4161-4. doi: 10.1016/j.vaccine.2015.04.036. Epub 2015 Apr 17.

    PubMed 25896383

Questions about this trial

What is this clinical trial studying?

A study testing abstract vs concrete texts in people with Vaccine Hesitancy, run by University of Bari Aldo Moro at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

vaccine hesitancy; number of participants accepting the vaccination (time frame: same day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05582564, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in